RNA-based therapeutics are gaining traction due to advancements in delivery technologies, despite historical challenges with ...

GEO-CM04S1 BARDA/Project NextGen Phase 2b trial preparations ongoing with manufacturing of clinical trial materials underway and clinical sites confirmed  Additional data evaluating GEO-CM04S1 as ...

EQS-News: GeoVax, Inc. / Key word (s): Financial GeoVax Reports 2024 Year-End Financial Results and Provides Business Update 27.03.2025 / 21:06 CET/CEST The issuer is solely responsible for the ...

Discover how RNA therapeutics are reshaping medicine, offering new treatments for previously undruggable targets.

Research team developed PathActMarker, a software package for pathway activity inference and analysis. It preprocesses gene ...

Full-year results and business updateClinical proof of principle obtained in Phase I adjuvant head and neck cancer trial with individualized ...